Delivery Order SPE2DR25D3109-SPE2DR26FT2UW

<p>The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for INGREZZA 40 mg capsule (30-count units), with an ultimate completion date of March 20, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency issued a $4,244.58 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for INGREZZA 80 mg capsule 30-count units, with an ultimate completion date of March 25, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. Pricing is firm fixed...

<p>The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for INGREZZA 40 MG capsules (30-count). The order was issued under the DLA Troop Support Medical IDC SPE2DX, a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price and an ultimate completion date of March 23, 2026.</p>

The Defense Logistics Agency issued a $7,748.14 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for INGREZZA 40 mg capsule 30-count units under firm fixed pricing. The order is placed against the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs...

The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for INGREZZA 40 mg capsule 30-count units, with an ultimate completion date of March 24, 2026. The order is issued under the parent Indefinite Delivery Contract held by Cencora, Inc. (Amerisourcebergen's parent) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This vehicle supplies pharmaceutical products and medical commodities to support military...

<p>The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for INGREZZA 40 MG Capsule 30S, with an ultimate completion date of March 16, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for INGREZZA 40 mg capsule (30-count) with a ceiling value of $3,874.06.</p> <p>Place of performance is Conshohocken, PA. The order is due for completion by March 10, 2026. Pricing is firm fixed price under a non-set-aside competitive award.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for INGREZZA 60 mg capsule 30-count units with a ceiling value of $4,267.66 under firm fixed-price terms. Place of performance is Conshohocken, PA. Ultimate completion date is March 24, 2026.</p>

<p>The Defense Logistics Agency issued a $4,267.66 delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for INGREZZA 60 mg capsule, 30-count units, with an ultimate completion date of March 13, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing with no set-aside used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for INGREZZA 80 mg capsule 30-count units, with a ceiling value of $4,244.58.</p> <p>Place of performance is Conshohocken, PA 19428. The ultimate completion date is March 2, 2026. The order is priced on a firm fixed-price basis and uses no set-aside.</p>